Gene · 407017
Papers3,057
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,057
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circ_0003314 Combines with the miR-26b-5p/IL1RAP Axis to Inhibit HTR-8/SVneo Cell Proliferation, Migration, Invasion and Tube Formation and Promote Apoptosis. | Appl Biochem Biotechnol | 2025 | 39141177 | PubTator, text mining | PubMed |
| Prospects for the Protective Mechanisms and Compounds of Bufei Huoxue Capsule against COVID-19 Convalescence: Evaluation of Integrating UHPLC-HRMS Analysis and Network Pharmacology Strategy. | Comb Chem High Throughput Screen | 2025 | 38920066 | PubTator, text mining | PubMed |
| Interplay of miR-542, miR-126, miR-143 and miR-26b with PI3K-Akt is a Diagnostic Signal and Putative Regulatory Target in HPV-Positive Cervical Cancer. | Biochem Genet | 2025 | 38849709 | PubTator, text mining | PubMed |
| Assessment of salivary microRNA by RT-qPCR: Facing challenges in data interpretation for clinical diagnosis. | PLoS One | 2024 | 39656703 | PubTator, text mining | PubMed |
| Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. | Signal Transduct Target Ther | 2024 | 39627201 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Biomarkers of Pregnancy Complications. | Int J Mol Sci | 2024 | 39596014 | PubTator, text mining | PubMed |
| Circulating Micro-RNAs Predict the Risk of Recurrence in Triple-Negative Breast Cancer. | Cells | 2024 | 39594632 | PubTator, text mining | PubMed |
| Peripheral Brain-Derived Neurotrophic Factor (BDNF) and Its Regulatory miRNAs as Biological Correlates of Impulsivity in Young Adults. | Metabolites | 2024 | 39452910 | PubTator, text mining | PubMed |
| Role of microRNAs in neutrophil extracellular trap formation and prevention: Systematic narrative review. | Mol Cell Probes | 2024 | 39389272 | PubTator, text mining | PubMed |
| Differential expression of ST6GALNAC1 and ST6GALNAC2 and their clinical relevance to colorectal cancer progression. | PLoS One | 2024 | 39348343 | PubTator, text mining | PubMed |
| Unraveling the relevance of SARS-Cov-2 infection and ferroptosis within the heart of COVID-19 patients. | Heliyon | 2024 | 39263089 | PubTator, text mining | PubMed |
| Nasal microRNA signatures for disease severity in infants with respiratory syncytial virus bronchiolitis: a multicentre prospective study. | BMJ Open Respir Res | 2024 | 39089741 | PubTator, text mining | PubMed |
| Spatiotemporal expression and control of haemoglobin in space. | Nat Commun | 2024 | 38862545 | PubTator, text mining | PubMed |
| MiR-26a and miR-191 are upregulated while PLAG1 and HIF2 are downregulated in pleomorphic adenomas of the salivary glands compared to Warthin tumors. | J Oral Pathol Med | 2024 | 38853518 | PubTator, text mining | PubMed |
| MicroRNA expression analysis in peripheral blood and soft-tissue of patients with periprosthetic hip infection. | Bone Jt Open | 2024 | 38839054 | PubTator, text mining | PubMed |
| Are miR-26a and miR-26b microRNAs potent prognostic markers of gestational diabetes? | Health Sci Rep | 2024 | 38831779 | PubTator, text mining | PubMed |
| The miR-26b/CTGF axis: A promising therapeutic mechanism for managing myocardial fibrosis post myocardial infarction. | Int J Cardiol | 2024 | 38761971 | PubTator, text mining | PubMed |
| MicroRNA expression profile of alveolar epithelial cells infected with Aspergillus fumigatus. | J Appl Genet | 2024 | 38727943 | PubTator, text mining | PubMed |
| IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p. | J Transl Med | 2024 | 38720389 | PubTator, text mining | PubMed |
| Pharmacological p38 MAPK inhibitor SB203580 enhances AML stem cell line KG1a chemosensitivity to daunorubicin by promoting late apoptosis, cell growth arrest in S-phase, and miR-328-3p upregulation. | Saudi Pharm J | 2024 | 38699598 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407017/papers?page=5